The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy (CROSBI ID 309066)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Bartalena, L. ; Kahaly, G. J. ; Baldeschi, L. ; Dayan, C. M. ; Eckstein, A. ; Marcocci, C. ; Marino, M. ; Vaidya, B. ; Wiersinga, W. M.
EUGOGO
engleski
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy
Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease (GD). Choice of treatment should be based on the assessment of clinical activity and severity of GO. Early referral to specialized centers is fundamental for most patients with GO. Risk factors include smoking, thyroid dysfunction, high serum level of thyrotropin receptor antibodies, radioactive iodine (RAI) treatment, and hypercholesterolemia.
Graves' orbitopathy ; guidelines
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
185 (4)
2021.
G43-G67
objavljeno
0804-4643
1479-683X
10.1530/eje-21-0479
Povezanost rada
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje), Farmacija, Interdisciplinarne prirodne znanosti, Javno zdravstvo i zdravstvena zaštita, Kliničke medicinske znanosti
